ASP Isotopes (NASDAQ:ASPI) Director Sells $312,500.00 in Stock

Posted by Geri Gentry on Jul 1st, 2026

ASP Isotopes Inc. (NASDAQ:ASPI – Get Free Report) Director Todd Wider sold 50,000 shares of the stock in a transaction on Monday, June 29th. The shares were sold at an average price of $6.25, for a total transaction of $312,500.00. Following the completion of the transaction, the director directly owned 722,247 shares in the company, valued at $4,514,043.75. This trade represents a 6.47% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

ASP Isotopes Stock Performance

Shares of ASPI stock traded down $0.05 during mid-day trading on Wednesday, hitting $6.17. 3,923,284 shares of the stock were exchanged, compared to its average volume of 4,990,399. The stock’s fifty day simple moving average is $6.24 and its two-hundred day simple moving average is $5.90. The company has a debt-to-equity ratio of 0.69, a quick ratio of 4.37 and a current ratio of 4.39. ASP Isotopes Inc. has a 12-month low of $3.92 and a 12-month high of $14.49. The stock has a market capitalization of $776.80 million, a price-to-earnings ratio of -2.97 and a beta of 3.51.

ASP Isotopes (NASDAQ:ASPI – Get Free Report) last issued its quarterly earnings data on Wednesday, May 20th. The company reported ($0.22) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.28) by $0.06. ASP Isotopes had a negative return on equity of 112.46% and a negative net margin of 644.40%.The company had revenue of $8.36 million during the quarter, compared to analysts’ expectations of $3.68 million.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Rovida Investment Management Ltd grew its stake in shares of ASP Isotopes by 45.5% in the 3rd quarter. Rovida Investment Management Ltd now owns 3,200,000 shares of the company’s stock valued at $30,688,000 after buying an additional 1,000,000 shares in the last quarter. SPX Gestao de Recursos Ltda acquired a new stake in ASP Isotopes in the third quarter valued at approximately $1,054,000. HITE Hedge Asset Management LLC acquired a new stake in ASP Isotopes in the fourth quarter valued at approximately $2,407,000. Rathbones Group PLC grew its position in ASP Isotopes by 68.6% in the fourth quarter. Rathbones Group PLC now owns 399,599 shares of the company’s stock worth $2,138,000 after acquiring an additional 162,535 shares in the last quarter. Finally, SBI Securities Co. Ltd. increased its stake in shares of ASP Isotopes by 196.2% during the 4th quarter. SBI Securities Co. Ltd. now owns 152,120 shares of the company’s stock worth $814,000 after purchasing an additional 100,769 shares during the last quarter. Hedge funds and other institutional investors own 16.80% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the company. Weiss Ratings restated a “sell (d-)” rating on shares of ASP Isotopes in a research note on Wednesday, June 24th. Canaccord Genuity Group reiterated a “buy” rating and set a $11.00 price objective on shares of ASP Isotopes in a research report on Tuesday, April 14th. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $13.00.

View Our Latest Stock Analysis on ASPI

ASP Isotopes Company Profile

(Get Free Report)

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.